Monday, November 27, 2006
Way More on the Fiorello Fiasco
It appears that the Fiorello story (discussed here) has wings. Check out the post at PharmaGossip for more.
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Email
Psychiatric medications, science, marketing, psychiatry in general, and occasionally clinical psychology. Questioning the role of key opinion leaders and the use of "science" to promote commercial ends rather than the needs of people with mental health concerns.
Blog Archive
-
▼
2006
(219)
-
▼
November
(69)
- Pfizer: Who Needs New Drugs
- Is Neuronetics Hiring?
- Even More Suicide Attempts in Clinical Trials with...
- Uh Oh Chuck They Out To Get Us Man: Stats
- How About Another Atypical Antipsychotic?
- Way More on the Fiorello Fiasco
- Brits Jump on CUtLASS -- Finally!
- Seroquel Says Sorry (Sort of)
- Cyberonics Gets Nailed!
- More Antipsychotics for Kids
- NYT: Kids Taking Lots of Psych Meds...
- AstraZeneca: Slapped Over Seroquel
- Blumsohn Keeps Fighting...
- Bribery Pays
- FDA: Pay Per DTC Ad Policy
- Atypical Antipsychotics vs. Older Meds: $$$
- Uh Oh Chuck They Out To Get Us Man: COI
- Required Reading on Mifepristone (RU-486)
- Seroquel Clinical Trials Update
- Are Patients Really Getting Better?
- What a BAD Piece in the New York Times
- Corcept: What Did I Tell You?
- Uh Oh Chuck They Out to Get Us Man: Authorship
- Over at Health Care Renewal...
- Occupational Therapy for Dementia...
- We Should TALK to People With Dementia?
- Atypical Antipsychotic Results (Guess)
- Lexapro For Life?
- Advertorial Update...
- Someone's Betting on Corcept
- Seroquel for Everything! (Except Weight Loss)
- A Reader Poll...
- Sponsored Editorial?
- Drug Firms Will NOT be Bullied...
- Assay Sensitivity or Efficacy?
- Academic Stalking?
- Mifepristone (RU-486): Move The Goalposts Wider
- New Drugs Save Lives (wink wink)
- Antidepressants and Suicide in Clinical Trials: Up...
- Welcome to Furious Seasons
- Seroquel for Anxiety? Say What??
- Quote of the Week
- When Blumsohn Speaks...
- Corcept: Still a Bad Investment
- Burying Conflicts of Interest
- Upcoming...
- DTC Marketing: A Good Investigation
- How do I Love PLoS Medicine?
- Cyberonics: Abandon Ship
- Happy Two Month Anniversary to CPP!
- Bipolar: It's Everywhere!
- Yet More Trouble for Newer Antipsychotics...
- Neurontin: Blast From the Past
- UK Pharma Flexes Its Electoral Might
- rTMS: What's the Real Story?
- Great Video Clip
- Just TOO funny!
- More on Cyberonics
- Greetings to Neuronetics!
- Upcoming...
- Bow to the Mighty PharmaGossip
- Paxil Lawsuit Update
- More on the Nemeroff Saga
- Atypical Anitpsychotics Disappoint A-G-A-I-N
- Fluoxetine and Self-Harm in Kids
- "Educational" Materials
- Reality is Stranger than Fiction: Rozerem Ads
- Conflicts of Interest on NPR
- COI Mentioned in Psychology
-
▼
November
(69)
Academia
Pharma: General
Psychiatry and Psychology
Scientific Misconduct
About Me
- CL Psych
- I'm an academic with a respectable amount of clinical experience and no drug industry funding. Given my lack of time, don't expect multiple daily updates. Certain things about clinical psychology, the drug industry, psychiatry, and academics drive me nuts, and you'll probably pick up on these pet peeves before long...
Translate this page
Subscribe Via Email
No comments:
Post a Comment